Strong Buy
Buy
Hold
Sell
Strong Sell
Consensus
| Date | Grading Company | New Grade | Previous Grade | Action | Price When Posted | News Title | Publisher |
|---|---|---|---|---|---|---|---|
| 2026-07-13 | Wells Fargo | Overweight | Overweight | Upgrade | $18.96 | Q32 Bio upgraded to Overweight at Wells Fargo after alopeci… | TheFly |
| 2026-07-13 | Oppenheimer | Outperform | Outperform | Hold | $17.6826 | Q32 Bio price target raised to $40 from $20 at Oppenheimer | TheFly |
| 2026-05-18 | Cantor Fitzgerald | Overweight | N/A | Initialise | $6.3 | Q32 Bio initiated with an Overweight at Cantor Fitzgerald | TheFly |
| 2026-03-10 | H.C. Wainwright | Buy | Buy | Hold | $6 | H.C. Wainwright Reiterates Buy Rating on Q32 Bio Inc. (QTTB… | StreetInsider |
| 2024-12-05 | BMO Capital | Outperform | N/A | Initialise | $23.69 | BMO Capital Starts Q32 Bio Inc. (QTTB) at Outperform | StreetInsider |
| 2024-10-23 | Raymond James | Strong Buy | N/A | Initialise | $47.78 | Q32 Bio initiated with a Strong Buy at Raymond James | TheFly |
| 2024-10-16 | Oppenheimer | Outperform | Outperform | Hold | $48.47 | Oppenheimer Reiterates Outperform Rating on Q32 Bio Inc. (Q… | StreetInsider |
| 2024-09-11 | Wells Fargo | Overweight | N/A | Initialise | $47.96 | Q32 Bio initiated with an Overweight at Wells Fargo | TheFly |
| 2024-06-17 | Guggenheim | Buy | N/A | Initialise | $18.61 | Q32 Bio initiated with a Buy at Guggenheim | TheFly |
| 2024-04-02 | Piper Sandler | Overweight | N/A | Initialise | $18 | Piper Sandler Starts Q32 Bio Inc. (QTTB) at Overweight, 'we… | StreetInsider |